These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21646759)

  • 1. [Advances in imaging modalities of hepatocellular carcinoma].
    Imai Y; Kogita S; Igura T; Sawai Y; Ohama H; Fukuda K; Seki Y; Takamura M; Okada M; Murakami T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jun; 108(6):916-27. PubMed ID: 21646759
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic imaging of hepatocellular carcinoma: recent progress.
    Kudo M
    Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver.
    Weishaupt D; Willmann JK; Lutz AM; Marincek B
    Eur Radiol; 2004 Jan; 14 Suppl 1():C5-6. PubMed ID: 15113059
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in the imaging of hepatocellular carcinoma.
    You MW; Kim SY; Kim KW; Lee SJ; Shin YM; Kim JH; Lee MG
    Clin Mol Hepatol; 2015 Mar; 21(1):95-103. PubMed ID: 25834808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity.
    Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
    Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K
    AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
    Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
    J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
    Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
    J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
    Sugimoto K; Moriyasu F; Yoshiyuki K; Imai Y
    J Med Ultrason (2001); 2014 Oct; 41(4):531-2. PubMed ID: 27278039
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles.
    Harvey CJ; Lim AK; Blomley MJ; Taylor-Robinson SD; Gedroyc WM; Cosgrove DO
    Eur Radiol; 2002 Dec; 12 Suppl 3():S70-3. PubMed ID: 12522608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
    Kitoh Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings.
    Lee DH; Kim SH; Lee JM; Park HS; Lee JY; Yi NJ; Suh KS; Jang JJ; Han JK; Choi BI
    Invest Radiol; 2009 Jun; 44(6):311-21. PubMed ID: 19462486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MR imaging of hepatocellular carcinoma using hepatocyte-specific contrast agent Gd-EOB-DTPA].
    Tanaka O; Nishimura T; Yamagami T; Ichijo Y; Ouchi H; Ohno K; Mitsumoto Y; Mori T; Yoshikawa T
    Nihon Shokakibyo Gakkai Zasshi; 2010 May; 107(5):703-11. PubMed ID: 20460843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.